Drug profile · INN
levorphanol tartrate
LEVO-DROMORAN
levorphanol tartrate (LEVO-DROMORAN) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — levorphanol tartrate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
levorphanol tartrate (LEVO-DROMORAN) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Mu opioid receptor agonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is levorphanol tartrate?
levorphanol tartrate (LEVO-DROMORAN) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for levorphanol tartrate?
LEVO-DROMORAN is a marketed brand name for levorphanol tartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levorphanol tartrate?
levorphanol tartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.